Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
May 19, 2026, 06:31 ET Netherton Syndrome Market Set to Expand During the Forecast Period (2026-2036) as Novel Therapies Enter Development Pipeline | DelveInsight
expected to grow during the forecast period (2026–2036), primarily driven by the launch of upcoming therapies such as QRX003 (Quoin Pharmaceuticals), BCX17725 (BioCryst Pharmaceuticals), ATR-12 (Azitra), and others. This anticipated growth reflects a shift in treatment dynamics, suggesting increased diagnosis,
More news about: DelveInsight Business Research, LLP
May 12, 2026, 08:00 ET As U.S. Housing Supply Stalls, Builders Capital Exchange Commits $2B+ Annually to Accelerate Homebuilding
ability to scale and contributed to ongoing supply and affordability challenges."BCX was founded on a simple idea: builders need capital that works the way single-family construction does," said Robert Trent, CEO of BCX. "As a former builder, I've lived the frustration of financing slowing projects down
More news about: Builders Capital Exchange